Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7

TRIM14 promotes chemoresistance in gliomas by activating Wnt/β-catenin signaling via stabilizing Dvl2

(2018) Zhanyao Tan et al.   ONCOGENE

Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway

(2018) Chao Yu et al.   Theranostics

TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-κB pathway

(2018) Ting-Ting Zhao et al.   Journal of Cancer

TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis

(2017) Shigetsugu Hatakeyama   TRENDS IN BIOCHEMICAL SCIENCES

miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8

(2017) Yao Liu et al.   OncoTargets and Therapy

MiR-26 enhances chemosensitivity and promotes apoptosis of hepatocellular carcinoma cells through inhibiting autophagy

(2017) Fangfang Jin et al.   Cell Death & Disease

Chemotherapy for advanced non-small cell lung cancer with a focus on squamous cell carcinoma

(2016) Kozo Kuribayashi et al.   Journal of Cancer Research and Therapeutics

Alternative splicing of spleen tyrosine kinase differentially regulates colorectal cancer progression

(2016) Beibei Ni et al.   Oncology Letters

Choose Delicately and Reuse Adequately: The Newly Revealed Process of Autophagy

(2015) Satoru Kobayashi   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells

(2015) Ryan Charles Pink et al.   GYNECOLOGIC ONCOLOGY

TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway

(2014) L-H Zhang et al.   ONCOGENE

In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non-small cell lung cancer cell lines

(2014) MIN-CONG WANG et al.   ONCOLOGY REPORTS

TRIM65 regulates microRNA activity by ubiquitination of TNRC6

(2014) S. Li et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Targeting miR-21 Induces Autophagy and Chemosensitivity of Leukemia Cells

(2013) Hugo Seca et al.   CURRENT DRUG TARGETS

Manipulation of autophagy in cancer cells: an innovative strategy to fight drug resistance

(2013) Francesca Aredia et al.   Future Medicinal Chemistry

MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity

(2013) Leibo Xu et al.   JOURNAL OF HEPATOLOGY

Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

(2013) X Sui et al.   Cell Death & Disease

Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

(2012) Xin-Sheng Deng et al.   CELL CYCLE

A Phase I Study of Erlotinib and Hydroxychloroquine in Advanced Non–Small-Cell Lung Cancer

(2012) Sarah B. Goldberg et al.   Journal of Thoracic Oncology

Autophagy: Renovation of Cells and Tissues

(2011) Noboru Mizushima et al.   CELL

Alterations of microRNAs in Cisplatin-resistant Human Non-small Cell Lung Cancer Cells (A549/DDP)

(2011) Qi Wang et al.   EXPERIMENTAL LUNG RESEARCH

The Role of Autophagy in Cancer: Therapeutic Implications

(2011) Z. J. Yang et al.   MOLECULAR CANCER THERAPEUTICS

The autophagic paradox in cancer therapy

(2011) W K K Wu et al.   ONCOGENE

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC

(2010) Alex Chang   LUNG CANCER

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1

(2009) Zhongxing Liang et al.   BIOCHEMICAL PHARMACOLOGY

miR-138 might reverse multidrug resistance of leukemia cells

(2009) Xiaohong Zhao et al.   LEUKEMIA RESEARCH

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

(2008) Lin Xia et al.   INTERNATIONAL JOURNAL OF CANCER